Marinus Pharmaceuticals News

Marinus Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

Jan 3 04:27

Marinus Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer

Dec 30, 2024 20:15

Marinus Pharmaceuticals | 8-K: Current report

Dec 30, 2024 20:15

Marinus Pharmaceuticals | 8-K: Current report

Dec 30, 2024 20:05

Marinus Pharmaceuticals | 8-K: Current report

Dec 24, 2024 05:08

Marinus Pharmaceuticals | 8-K: Current report

Dec 11, 2024 05:10

Marinus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 11, 2024 04:20

Marinus Pharmaceuticals | 8-K: Current report

Nov 15, 2024 21:04

Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Investments, Inc.(8.0%),James Healy(8.0%), etc.

Nov 15, 2024 07:41

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(0%),Bihua Chen(0%)

Nov 15, 2024 04:07

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(0.00%),Finny Kuruvilla, M.D. Ph. D.(0.00%), etc.

Nov 15, 2024 01:26

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Nov 14, 2024 23:38

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

Nov 14, 2024 22:37

Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 13, 2024 05:46

Marinus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 05:16

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.08%)

Nov 13, 2024 05:06

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jennison Associates LLC(0%)

Nov 12, 2024 23:00

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.08%)

Nov 5, 2024 02:45

Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(9.98%),Panacea Venture Healthcare Fund II, L.P.(9.98%), etc.

Nov 2, 2024 08:32

Marinus Pharmaceuticals | SCHEDULE 13G/A: Others

Nov 1, 2024 01:11